| 病毒株名 | SARS-CoV-2/human/KOR/KCDC03/2020 |
| 序列号 | MT020782.1 |
| 宿主 | Homo sapiens |
| 数据来源 | GenBank |
| 采样日期 | 2020-01-25 |
| 采样地点 | South Korea / Gyeonggi-do |
| 相关ID | EPI_ISL_407193 |
| 谱系 | A (Version: 2022-01-05) |
| 序列完整度 | Complete |
| 质量评估 | 0/0/0/4/NO |
| 样本提供单位 | Korea Centers for Disease Control & Prevention (KCDC) Center for Laboratory Control of Infectious Diseases Division of Viral Diseases |
| 数据递交单位 | Korea Centers for Disease Control & Prevention (KCDC) Center for Laboratory Control of Infectious Diseases Division of Viral Diseases |
| 发布时间 | 2020-02-05 03:35:50 |
| 年龄 | NA |
| 性别 | NA |
| 职业 | NA |
| 发作日期 | NA |
| 入院日期 | NA |
| 旅行史/接触史 | NA |
| 严重程度 | NA |
| 病患状态 | The patient had self-administered antipyretics for initial symptoms such as chills and fever. The patient had experienced intermittent coughing with sputum 3 days after the administration of antipyretics |
| 临床症状及潜伏天数 | Chills, fever, intermittent coughing with sputum |
| 临床检测 | Nasopharyngeal and oropharyngeal swab and sputum samples were collected from symptomatic patients to detect SARS-CoV-2 by real-time reverse transcriptase (RT)-PCR |
| 基础病史 | NA |
| 其他病原菌感染 | NA |
| 合并症 | NA |
| 临床用药和处理 | Self-administered antipyretics |
| 生理生化指标追踪 | NA |
| 出院日期 | NA |
| 相关文献 | Identification of Coronavirus Isolated from a Patient in Korea with COVID-19. [PMID: 32149036] |
| 参考序列 | 2019-nCoV (MN908947.3) |
| 病毒株名 | hCoV-19/South Korea/KCDC03/2020 (MT020782.1) |
| SNP数目 | 4 |
| Insertion数目 | 0 |
| Deletion数目 | 2 |
| Indel数目 | 0 |
| 相似度 | 99.98 |
| 质量评估分级 | A |
| 注释统计 | 6(synonymous_variant:2; intergenic_variant:2; missense_variant:2) |
| 文件下载 (GFF3) |
| 变异位点 | 参考碱基 | 碱基变化 | 基因位置密码子 | 蛋白质氨基酸变化 |
|---|